BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer

[1] Botha JL(2003)Breast cancer incidence and mortality trends in 16 European countries Eur J Cancer 39 1718-1729

[2] Bray F(2013)Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010 Cancer Res Treat 45 1-14

[3] Sankila R(2013)Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells Nat Commun 4 2443-2407

[4] Parkin DM(2009)Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton J Cell Mol Med 13 2396-602

[5] Jung KW(2019)Risk prediction for breast Cancer in Han Chinese women based on a cause-specific Hazard model BMC Cancer 19 128-11475

[6] Won YJ(2005)Breast cancer metastasis: markers and models Nat Rev Cancer 5 591-22768

[7] Kong HJ(2007)Clonal selection of metastasis within the life history of a tumor Cancer Res 67 11471-103

[8] Oh CM(2016)Phosphorylation impacts N-end rule degradation of the proteolytically activated form of BMX kinase J Biol Chem 291 22757-173

[9] Seo HG(2012)Tec family kinases in inflammation and disease Int Rev Immunol 31 87-380

[10] Lee JS(2012)BMX and its role in inflammation, cardiovascular disease, and cancer Int Rev Immunol 31 166-962

[1] Botha JL(2003)Breast cancer incidence and mortality trends in 16 European countries Eur J Cancer 39 1718-1729

[2] Bray F(2013)Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010 Cancer Res Treat 45 1-14

[3] Sankila R(2013)Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells Nat Commun 4 2443-2407

[4] Parkin DM(2009)Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton J Cell Mol Med 13 2396-602

[5] Jung KW(2019)Risk prediction for breast Cancer in Han Chinese women based on a cause-specific Hazard model BMC Cancer 19 128-11475

[6] Won YJ(2005)Breast cancer metastasis: markers and models Nat Rev Cancer 5 591-22768

[7] Kong HJ(2007)Clonal selection of metastasis within the life history of a tumor Cancer Res 67 11471-103

[8] Oh CM(2016)Phosphorylation impacts N-end rule degradation of the proteolytically activated form of BMX kinase J Biol Chem 291 22757-173

[9] Seo HG(2012)Tec family kinases in inflammation and disease Int Rev Immunol 31 87-380

[10] Lee JS(2012)BMX and its role in inflammation, cardiovascular disease, and cancer Int Rev Immunol 31 166-962